KPMA chief to give warning to drugmakers

Published: 2009-03-11 06:59:00

Updated: 2009-03-11 06:59:00

Korea Pharmaceutical Manufacturers Association (KPMA) Chairman Ur Choon-sun will issue a strong warning to drug manufacturers over their irregular business practices in a forthcoming meeting in order to induce voluntary reform in the pharmaceutical industry.

The meeting is scheduled for March ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK